drugset / Trial / NCT00600509

Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method

NCT00600509

Phase 2 Completed 216 enrolled UCB Pharma UCB Japan Co. Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Double-blind, randomized, placebo-controlled, multi center trial to evaluate the efficacy and safety of levetiracetam as adjunctive treatment in adult Japanese epileptic subjects with partial onset seizures.

Timeline

Start
2001-01
Primary completion
2003-07
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified

Indications